Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
(2) Prof. (Dr.) Kashmira J. Gohil, Director/Dean, Anand College of Pharmacy, Sharda Group of Institutions (SGI), Agra, India.
Reviewers:
(1) Maykon Jhuly Martins de Paiva, University of Gurupi, Brazil.
(2) Mohammed Nader Shalaby, Suez Canal University, Egypt.
(3) Umesh D Laddha, MET’s Institute of Pharmacy, India.
Additional Reviewers:
(1) Amel Hussaein Mussa, AL- Mustansiriya University, Iraq.
(2) Jay L. Wenger, HACC: Central Pennsylvania’s Community College, USA.
(3) Prashant Gajbhare, Govt Medical College Aurangabad, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.16/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Maykon Jhuly Martins de Paiva, Brazil) | File 1 | File 2
Stage 2 | Peer review report_2 (Mohammed Nader Shalaby, Egypt) | File 1 | File 2
Stage 2 | Peer review report_3 (Umesh D Laddha, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA